COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:
NIH staff guidance on coronavirus (NIH Only)

Current Drug Development Projects

Title Disorder PI Investor Contacts Institution
Non-Addictive Angiotensin AT2 Inhibitors for Neuropathic Pain Relief Neuropathic Pain Katritch, Vsevolod Katritch, Vsevolod University of Southern California
Novel Atypical Dopamine Modulators as Cocaine Pharmacotherapies Novel Atypical Dopamine Modulators as Cocaine Pharmacotherapies Childers, Steven R Childers, Steven R Encepheal Therapeutics, Inc
Optimization of Soluble Gamma-secretase Modulators for the Treatment of Alzheimer Alzheimer's Disease Wagner, Steven Lee Medeiros, Nelson UC San Diego, Massachusetts General Hospital
Orexin Receptor Antagonists for Drug Addiction and Panic Disorder Drug Addiction Kenny, Paul J Kenny, Paul J. Eolas Therapeutics, Inc.
RNA Targeted Drug Discovery and Development for Parkinson’s Disease Parkinson's disease Mouradian, Maral Mouradian, Maral RBHS-Robert Wood Johnson Medical School
Small molecule drugs for treatment of dry age-related macular degeneration Age-Related Macular Degeneration Petrukhin, Konstantin Petrukhin, Konstantin Columbia University
The Development of Small Molecule Inhibitors for Gaucher Disease Type 3 Gaucher Disease Type 3 Shayman, James Shayman, James University of Michigan